Funds and ETFs Granules India Limited

Equities

GRANULES

INE101D01020

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:50 2024-05-09 am EDT 5-day change 1st Jan Change
392 INR -4.61% Intraday chart for Granules India Limited -7.28% -3.29%

ETFs positioned on Granules India Limited

Name Weight AuM 1st Jan change Investor Rating
0.01% 4 M€ -4.41% -
0.01% 0 M€ +4.02% -
0.00% 0 M€ +3.48% -
Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceuticals products segment. Its geographical segments include within India and outside India. The Company has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It has over eight manufacturing facilities, approximately seven of which are located in India and one in the United States. The Company sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific and India. The Company’s wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
392 INR
Average target price
483.4 INR
Spread / Average Target
+23.31%
Consensus
  1. Stock Market
  2. Equities
  3. GRANULES Stock
  4. Funds and ETFs Granules India Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW